Eltrombopag, low-dose rituximab, and dexamethasone combination as frontline treatment of newly diagnosed immune thrombocytopaenia

被引：23
|
作者：
Gomez-Almaguer, David [1 ,2 ]
Colunga-Pedraza, Perla R. [1 ,2 ]
Gomez-De Leon, Andres [1 ,2 ]
Gutierrez-Aguirre, Cesar H. [1 ,2 ]
Cantu-Rodriguez, Olga G. [1 ,2 ]
Jaime-Perez, Jose C. [1 ,2 ]
机构：
[1] Univ Autonoma Nuevo Leon, Fac Med, Monterrey, Nuevo Leon, Mexico
[2] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Haematol Serv, Monterrey, Nuevo Leon, Mexico
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 02期
关键词：
immune thrombocytopenia; eltrombopag; rituximab; dexamethasone; THERAPY;
D O I：
10.1111/bjh.15070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 290
页数：3
相关论文
共 50 条
  • [1] Low-dose rituximab, eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, D.
    Colunga-Pedraza, P. R.
    Cantu-Rodriguez, O. G.
    Jaime-Perez, J. C.
    Gutierrez-Aguirre, C. H.
    Tarin-Arzaga, L.
    Sanchez-Cardenas, M.
    Sotomayor-Duque, G.
    Lozano-Morales, R. E.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 : 50 - 51
  • [2] Eltrombopag, Low-Dose Rituximab, and High-Dose Dexamethasone Combination for Patients with Newly Diagnosed Immune Thrombocytopenia: A Pilot "Total Therapy" Study
    Gomez-Almaguer, David
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Jaime-Perez, Jose Carlos
    Tarin-Arzaga, Luz C.
    Cardenas, Monica Sanchez
    Lozano-Morales, Rosa Elena
    Duque, Guillermo Sotomayor
    Cardenas-Araujo, Daniela
    Gomez-de Leon, Andres
    Santana-Hernandez, Paola
    Colunga-Pedraza, Perla Rocio
    BLOOD, 2016, 128 (22)
  • [3] Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults
    Gomez-Almaguer, David
    Herrera-Rojas, Miguel A.
    Jaime-Perez, Jose C.
    Gomez-De Leon, Andres
    Cantu-Rodriguez, Olga G.
    Gutierrez-Aguirre, Cesar H.
    Tarin-Arzaga, Luz
    Hernandez-Reyes, Jesus
    Ruiz-Arguelles, Guillermo J.
    BLOOD, 2014, 123 (25) : 3906 - 3908
  • [4] Low-dose rituximab plus high-dose dexamethasone in newly diagnosed immune thrombocytopenia
    Coronado-Alejandro, Edgar Ulises
    Martinez-Hernandez, Juan Pablo
    Gomez-De Leon, Andres
    Colunga-Pedraza, Perla Rocio
    Jaime-Perez, Jose Carlos
    Cantu-Rodriguez, Olga Graciela
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (06) : 778 - 779
  • [5] Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study
    Colunga-Pedraza, Perla R.
    De la Garza-Salazar, Fernando
    Vaquera-Alfaro, Hector A.
    Gomez-De Leon, Andres
    Bustillos-Munoz, Monica
    Tarin-Arzaga, Luz
    Cantu-Rodriguez, Olga
    Gutierrez-Aguirre, Cesar Homero
    Gomez-Almaguer, David
    BRITISH JOURNAL OF HAEMATOLOGY, 2024,
  • [6] Romiplostim, Low-Dose Rituximab and High-Dose Dexamethasone Combination in Newly Diagnosed Immune Thrombocytopenia: Another "Total Therapy" Pilot Study
    Colunga-Pedraza, Perla R. R.
    Bustillos Munoz, Monica
    De La Garza, Fernando
    Gomez-De Leon, Andres
    Ulises Coronado-Alejandro, Edgar
    Gomez Gomez, Eliezer Tomas
    Varela-Constantino, Ana
    De la rosa-Flores, Gerardo A.
    Cantu Rodriguez, Olga Graciela
    Homero Gutierrez-Aguirre, Cesar
    Tarin Arzaga, Luz del Carmen
    Gomez-Almaguer, David
    BLOOD, 2021, 138
  • [7] Refractory immune thrombocytopenia responding to combination therapy of eltrombopag and low-dose rituximab: a case series
    Chu, Tan-Huy
    Huynh, Thien-Ngon
    Trinh-Le, Quoc-Vu
    Phu, Chi-Dung
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S299 - S304
  • [8] Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial
    Liu, Qi
    Shen, Yingying
    Shou, Lihong
    Xia, Yongming
    Chen, Sai
    Zhou, Mei
    Xu, Xiaohua
    Wu, Liqiang
    Zhao, Jian-Zhi
    Dong, Xiaohui
    Xu, Linglong
    Rong, Chunmeng
    Qiu, Di
    Liu, Wenbin
    Hu, Huijin
    Zhao, Yuechao
    Zhang, Yun
    Li, Linjie
    Xie, Yaping
    Xu, Xiaojun
    Jiang, Huifang
    Zeng, Hui
    Fu, Jiaping
    Huang, Li
    Lin, Xia
    Chen, Dan
    Zhou, Yuhong
    Ye, Baodong
    Shen, Yiping
    Wu, Dijiong
    BLOOD, 2024, 144 : 3949 - 3950
  • [9] Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
    Yao, Mingkang
    Zhang, Jingjing
    Li, Ying
    Lv, Linlin
    Jia, Lu
    Yang, Chunyan
    Huang, Yu
    Liu, Haihui
    Wang, Jian
    Chen, Mingtai
    Zhang, Hao
    MEDICINE, 2022, 101 (04) : E28679
  • [10] Clinical Efficacy and Safety of High-Dose Dexamethasone Plus Low-Dose Rituximab as First-Line Therapy in Newly Diagnosed Primary Immune Thrombocytopenia
    Hu Zhou
    Liu Liu
    Xinhui Shu
    Xiaoran Wang
    Yongping Song
    Indian Journal of Hematology and Blood Transfusion, 2019, 35 : 507 - 512
12345